Researchers find protein that marks difference between cancer and non-cancer cells

March 8, 2018, University of Alberta Faculty of Medicine & Dentistry
UAlberta biochemistry professor Michael Overduin is part of a research team that discovered a modified protein that is overused by cancerous cells to effectively prevent healthy ones from sorting material in the way they were designed to. Credit: Ross Neitz

A discovery sheds light on how cancerous cells differ from healthy ones, and could lead to the development of new strategies for therapeutic intervention for difficult-to-treat cancers in the future.

An international team of investigators found a "stop sign"—a modified protein researchers named a PIP-stop—inside cells that are overused by that effectively prevents healthy ones from sorting material in the way they were designed to.

"We have discovered that breast cancer, leukemia, lymphoma and have too many PIP-stops. This would upset , and opens up a new avenue for developing drugs that block PIP-stop formation by kinase enzymes," said Michael Overduin, a University of Alberta cancer researcher and professor of biochemistry, who led the research project.

The team named the modification a PIP-stop because it stops proteins from interacting with lipid molecules called PIP.

Before making their discovery, the researchers first solved the 3-D structure of a sorting nexin protein, which is key to sorting proteins to their proper locations within the cell. Powerful magnets in the U.K. and in the National High Field Nuclear Magnetic Resonance Centre (NANUC), Canada's national magnet lab based in Edmonton, were then used to detect signals from within individual atoms within the .

By focusing on the protein structure, the team was able to discover the PIP-stop and see how it blocked the protein's function. The PIP-stop is a phosphate which is added to the that binds the PIP lipid, and normally controls how proteins attach to membranes.

Samples from cancer patients have too many PIP-stops, which could lead to the unregulated growth seen in tumour cells. Similar PIP-stops were found to be overused in a large number of other proteins involved in other cancer types, where they could also influence tumour growth.

"Our goal now is to design inhibitors for the overactive kinases that create PIP-stops, and to use this information to design drug molecules that block the progression of cancers, particularly those which lack effective treatments," said Overduin.

Explore further: Researchers identify a crucial protein that commands a key communications hub determining cell growth

More information: Marc Lenoir et al, Phosphorylation of conserved phosphoinositide binding pocket regulates sorting nexin membrane targeting, Nature Communications (2018). DOI: 10.1038/s41467-018-03370-1

Related Stories

Researchers identify a crucial protein that commands a key communications hub determining cell growth

January 3, 2018
National University of Singapore biologists have identified a crucial protein that commands a key communications hub which determines cell growth.

Study discovers proteins which suppress the growth of breast cancer tumors

June 12, 2017
Researchers at the University of Birmingham have found that a type of protein could hold the secret to suppressing the growth of breast cancer tumours.

New kinase detection method helps identify targets for developing cancer drugs

September 21, 2017
Purdue University researchers have developed a high-throughput method for matching kinases to the proteins they phosphorylate, speeding the ability to identify multiple potential cancer drug targets.

Map of substrate-kinase interactions may lead to more effective cancer drugs

March 27, 2012
(Medical Xpress) -- Later-stage cancers thrive by finding detours around roadblocks that cancer drugs put in their path, but a Purdue University biochemist is creating maps that will help drugmakers close more routes and ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Recommended for you

A new tactic for starving tumors

June 25, 2018
A tumor's goal is simple: to grow, grow, grow, by making more cancer cells. But that often means growing so fast that the oxygen supply gets scarce, at which point cells within the tumor start to suffocate. Without oxygen, ...

Immune profile for successful cancer immunotherapy discovered

June 25, 2018
In a new study published online June 25, 2018 in Nature Medicine, UC San Francisco researchers have identified a key biological pathway in human cancer patients that appears to prime the immune system for a successful response ...

'Embattled' breast cancer drugs could be revived by new discovery

June 25, 2018
More than 60 percent of breast cancer cases involve defects in the same biochemical chain of events within cancer cells—known as the PI3 kinase (PI3K) pathway—but efforts to develop therapies targeting this pathway have ...

Lethal prostate cancer treatment may benefit from combination immunotherapy

June 25, 2018
Researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy (BKI) released a study investigating the use of combination checkpoint immunotherapy in the treatment of a ...

New drugs are improving survival times for patients with aggressive type of blood cancer, study finds

June 25, 2018
Survival times for a highly aggressive type of blood cancer have nearly doubled over the last decade due to the introduction of new targeted drugs, a Yorkshire study has shown.

Dying cancer cells make remaining glioblastoma cells more aggressive and therapy-resistant

June 21, 2018
A surprising form of cell-to-cell communication in glioblastoma promotes global changes in recipient cells, including aggressiveness, motility, and resistance to radiation or chemotherapy.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.